GOFINTECH QUANT(00290) The single largest shareholder will be changed to IVD MEDICAL(01931) and trading will resume in the afternoon.
Guofu Quantum (00290) announced that the company was notified by its largest single shareholder, Dr. Liu Zhiwei, and shareholder Mr. Wang Tao...
GOFINTECH QUANT(00290) announced that the company's single largest shareholder, Dr. Liu Zhiwei, and shareholder Mr. Wang Tao, have informed the company that on September 1, 2025, Dr. Liu Zhiwei, together with AI International Capital Management Ltd. (wholly owned by Dr. Liu Zhiwei), Caitex Technology Holdings Limited (wholly owned by Chun Da International Capital Management Limited, which is wholly owned by Dr. Liu Zhiwei), and Mr. Wang Tao (collectively the "seller") have entered into a sale and purchase agreement with FINAL TOUCH LTD. (the buyer), to conditionally sell a total of approximately 1.8485 billion shares of the company, equivalent to approximately 20.31% of the total issued share capital of the company as of the date of this announcement, for a consideration of approximately HK$3.142 billion. The buyer is a wholly owned subsidiary of IVD MEDICAL (01931).
The completion of the sale is subject to the satisfaction (or waiver) of certain conditions precedent as set out in the sale and purchase agreement.
Following the completion of the sale and purchase agreement, Dr. Liu Zhiwei will directly and indirectly hold a total of 88.328 million shares (approximately 0.97% of the total issued share capital of the company), and will no longer be the company's single largest shareholder. Mr. Wang Tao will directly hold approximately 90.373 million shares (approximately 0.99% of the total issued share capital of the company), while the buyer and its ultimate controlling company IVD MEDICAL will hold approximately 1.8485 billion shares of the company (approximately 20.31% of the total issued share capital of the company), and will become the company's single largest shareholder. The board of directors expects that the sale or change in the company's single largest shareholder will not have any significant adverse impact on the company's daily operations.
In addition, the company has applied to the Stock Exchange for the resumption of trading in the company's shares from 1:00 p.m. on September 1, 2025.
Related Articles

"" commented on KeLing AI: domestic large models are deeply integrating into the industry

Sunflower Pharmaceutical Group (002737.SZ): Hydrochloride Fexofenadine Oral Suspension Obtains Drug Registration Certificate

Shandong Hualu-Hengsheng Chemical(600426.SH): Production facilities resume production after maintenance and repair.
"" commented on KeLing AI: domestic large models are deeply integrating into the industry

Sunflower Pharmaceutical Group (002737.SZ): Hydrochloride Fexofenadine Oral Suspension Obtains Drug Registration Certificate

Shandong Hualu-Hengsheng Chemical(600426.SH): Production facilities resume production after maintenance and repair.

RECOMMEND

EU Proposes Legislation to Enact Transatlantic Trade Framework by Eliminating Select U.S. Tariffs and Reducing Auto Duties to 15%
29/08/2025

Six Months In, WuXi Juno’s Revenue Just Exceeds RMB 100 Million as Commercialization of High-Priced Cancer Therapy Stalls
29/08/2025

Offshore Renminbi Briefly Exceeds 7.12 for First Time in Nearly Ten Months, Future Trajectory Under Scrutiny
29/08/2025